by Martin Lee | published by Project CBD on March 26, 2020
Project CBD honors the huge contribution of women leaders in the burgeoning field of cannabinoid research
During a time of great crisis, we are reminded of the importance of medical science and the expert researchers who have dedicated their lives to advancing public health. In that context, we want to acknowledge Women’s History Month and celebrate the accomplishments of ten women who have made significant contributions to the advancement of cannabinoid science.
Allyn Howlett, PhD, is a pioneer neuropharmacologist known for her groundbreaking discovery of the CB1 cannabinoid receptor in 1988. Initially identified by Howlett and her graduate student, William Devane, at the St. Louis School of Medicine, CB1 receptors are the most abundant G-protein coupled receptors in the mammalian brain. This discovery opened the floodgates of research into the endocannabinoid system with huge implications for nearly every area of medical science. Howlett is currently a professor in the Department of Physiology and Pharmacology at the Wake Forest School of Medicine in Winston-Salem, North Carolina, where the Howlett Lab is studying protein interactions that modulate cannabinoid receptor activity in an effort to advance the development of new cannabinoid medicines. Read more here.
Cecilia Hillard, PhD, is the Associate Dean for Research and Director of the Neuroscience Research Center at the Medical College of Wisconsin in Milwaukee, where her lab focuses on the pharmacology and biochemistry of cannabinoids and endocannabinoids. Her work has contributed significantly to understanding how cannabinoids regulate immune function and the role of endocannabinoid signaling in the regulation of mood and responses to stress. An outstanding mentor to medical students and scientists, Hillard is the recipient of many honors, including the Lifetime Achievement Award from the International Cannabinoid Research Society (ICRS). She currently serves as executive director of the ICRS.